251 related articles for article (PubMed ID: 17526541)
21. Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen?
Ljungberg P; Haltia A; Kuusela P; Jalanko H; Holmberg C; Holthöfer H
Exp Nephrol; 1996; 4(5):286-94. PubMed ID: 8931984
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.
Lai KW; Wei CL; Tan LK; Tan PH; Chiang GS; Lee CG; Jordan SC; Yap HK
J Am Soc Nephrol; 2007 May; 18(5):1476-85. PubMed ID: 17429054
[TBL] [Abstract][Full Text] [Related]
23. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
[TBL] [Abstract][Full Text] [Related]
24. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
25. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S
Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161
[TBL] [Abstract][Full Text] [Related]
26. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
Koike K; Tsuboi N; Utsunomiya Y; Kawamura T; Hosoya T
Am J Nephrol; 2011; 34(6):542-8. PubMed ID: 22123493
[TBL] [Abstract][Full Text] [Related]
27. Charge and size selectivity of proteinuria in children with idiopathic nephrotic syndrome.
Taylor GM; Neuhaus TJ; Shah V; Dillon S; Barratt TM
Pediatr Nephrol; 1997 Aug; 11(4):404-10. PubMed ID: 9260234
[TBL] [Abstract][Full Text] [Related]
28. Anti-proteinuric effects of glycosaminoglycan-based drugs.
Wijnhoven T; Lensen JF; Rops AL; McCarthy KJ; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
Curr Opin Mol Ther; 2007 Aug; 9(4):364-77. PubMed ID: 17694449
[TBL] [Abstract][Full Text] [Related]
29. [Expression of nephrin, podocin and a-actinine-4 in renal tissue of patients with proteinuria].
Arias LF; Vieco BE; Arteta AA
Nefrologia; 2009; 29(6):569-75. PubMed ID: 19936002
[TBL] [Abstract][Full Text] [Related]
30. Glomerular podocytopathy in patients with systemic lupus erythematosus.
Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
[TBL] [Abstract][Full Text] [Related]
31. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome.
Vermylen C; Levin M; Mossman J; Barratt TM
Pediatr Nephrol; 1989 Apr; 3(2):122-9. PubMed ID: 2534970
[TBL] [Abstract][Full Text] [Related]
32. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
33. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
34. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
[TBL] [Abstract][Full Text] [Related]
35. Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics.
Wijnhoven TJ; Lensen JF; Rops AL; van der Vlag J; Kolset SO; Bangstad HJ; Pfeffer P; van den Hoven MJ; Berden JH; van den Heuvel LP; van Kuppevelt TH
Am J Kidney Dis; 2006 Aug; 48(2):250-61. PubMed ID: 16860191
[TBL] [Abstract][Full Text] [Related]
36. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
[TBL] [Abstract][Full Text] [Related]
37. Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
Matsuura K; Uesugi N; Hijiya N; Uchida T; Moriyama M
Hum Pathol; 2007 Mar; 38(3):410-9. PubMed ID: 17239933
[TBL] [Abstract][Full Text] [Related]
38. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
39. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
40. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies.
Drakopoulos A; Goumenos DS; Vlachojannis JG; Tsakas S
Ren Fail; 2006; 28(6):461-7. PubMed ID: 16928614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
